Half-year report · Q2

Period2024-04-01 → 2024-09-30
Filed2024-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥11.4bn2024-04-01 → 2024-09-30Cons.Net sales
Revenue¥20.4bn2023-04-01 → 2024-03-31Cons.Net sales (5-year summary)
Revenue¥10.5bn2023-04-01 → 2023-09-30Cons.Net sales
Operating income¥1.9bn2024-04-01 → 2024-09-30Cons.Operating income
Operating income¥1.7bn2023-04-01 → 2023-09-30Cons.Operating income
Ordinary income¥1.9bn2024-04-01 → 2024-09-30Cons.Ordinary income
Ordinary income¥3.2bn2023-04-01 → 2024-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.8bn2023-04-01 → 2023-09-30Cons.Ordinary income
Profit before tax¥2.1bn2024-04-01 → 2024-09-30Cons.Income before income taxes
Profit before tax¥1.8bn2023-04-01 → 2023-09-30Cons.Income before income taxes
Net income (owners)¥1.3bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.2bn2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.2bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income¥1.5bn2024-04-01 → 2024-09-30Cons.Profit loss
Net income¥1.2bn2023-04-01 → 2023-09-30Cons.Profit loss
Total assets¥32.6bnat 2024-09-30Cons.Assets
Total assets¥31.5bnat 2024-03-31Cons.Assets
Total assets¥30.1bnat 2023-09-30Cons.Total assets (5-year summary)
Total liabilities¥8.2bnat 2024-09-30Cons.Liabilities
Total liabilities¥7.9bnat 2024-03-31Cons.Liabilities
Net assets / equity¥24.4bnat 2024-09-30Cons.Net assets
Net assets / equity¥23.6bnat 2024-03-31Cons.Net assets
Net assets / equity¥22.5bnat 2023-09-30Cons.Net assets (5-year summary)
Cash and deposits¥15.7bnat 2024-09-30Cons.Cash and deposits
Cash and deposits¥14.0bnat 2024-03-31Cons.Cash and deposits
Cash & equivalents¥15.7bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥14.0bnat 2024-03-31Cons.Cash and cash equivalents
Cash & equivalents¥13.3bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥12.8bnat 2023-03-31dCons.Cash and cash equivalents
Operating cash flow¥1.2bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥3.0bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥1.5bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Investing cash flow¥1.1bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥883m2023-04-01 → 2024-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥149m2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥703m2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥998m2023-04-01 → 2024-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥985m2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥170.42024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥280.512023-04-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥155.762023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio70.3%at 2024-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio70.7%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio71.0%at 2023-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentrevenue2024-04-01 → 2024-09-30¥1.4bn
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentrevenue external2024-04-01 → 2024-09-30¥1.4bn
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentsegment profit2024-04-01 → 2024-09-30¥215m
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentrevenue2024-04-01 → 2024-09-30¥9.9bn
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentrevenue external2024-04-01 → 2024-09-30¥9.9bn
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentsegment profit2024-04-01 → 2024-09-30¥1.6bn
—segment totalrevenue2024-04-01 → 2024-09-30¥11.4bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥11.4bn
—segment totalsegment profit2024-04-01 → 2024-09-30¥1.9bn
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentrevenue2023-04-01 → 2023-09-30¥1.3bn
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentrevenue external2023-04-01 → 2023-09-30¥1.3bn
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentsegment profit2023-04-01 → 2023-09-30¥194m
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentrevenue2023-04-01 → 2023-09-30¥9.2bn
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentrevenue external2023-04-01 → 2023-09-30¥9.2bn
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentsegment profit2023-04-01 → 2023-09-30¥1.5bn
—segment totalrevenue2023-04-01 → 2023-09-30¥10.5bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥10.5bn
—segment totalsegment profit2023-04-01 → 2023-09-30¥1.7bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 506
ItemContextValueUnit
Independent auditors report consolidated (text)FilingDateInstantText · Plus
Audit firm1 consolidatedFilingDateInstant
Original text (Japanese)有限責任 あずさ監査法人
Cpa1 audit firm1 consolidatedFilingDateInstant
Original text (Japanese)西  野  裕  久
Cpa2 audit firm1 consolidatedFilingDateInstant
Original text (Japanese)河  野  匡  伸
Number of submissionFilingDateInstant1
Net sales (5-year summary)Prior1YTDDuration10452775000JPY
Net sales (5-year summary)CurrentYTDDuration11361310000JPY
Net sales (5-year summary)Prior1YearDuration20414865000JPY
Ordinary income loss (5-year summary)Prior1YTDDuration1764686000JPY
Ordinary income loss (5-year summary)CurrentYTDDuration1949901000JPY
Ordinary income loss (5-year summary)Prior1YearDuration3227183000JPY
Profit loss attributable to owners of parent (5-year summary)Prior1YTDDuration1193912000JPY
Profit loss attributable to owners of parent (5-year summary)CurrentYTDDuration1306125000JPY
Profit loss attributable to owners of parent (5-year summary)Prior1YearDuration2150143000JPY
Comprehensive income (5-year summary)Prior1YTDDuration1386338000JPY
Comprehensive income (5-year summary)CurrentYTDDuration1470630000JPY
Comprehensive income (5-year summary)Prior1YearDuration2470774000JPY
Net assets (5-year summary)Prior1QuarterInstant22543199000JPY
Net assets (5-year summary)CurrentQuarterInstant24409304000JPY
Net assets (5-year summary)Prior1YearInstant23627347000JPY
Total assets (5-year summary)Prior1QuarterInstant30053642000JPY
Total assets (5-year summary)CurrentQuarterInstant32633462000JPY
Total assets (5-year summary)Prior1YearInstant31544761000JPY
Basic earnings loss per share (5-year summary)Prior1YTDDuration155.76
Basic earnings loss per share (5-year summary)CurrentYTDDuration170.40
Basic earnings loss per share (5-year summary)Prior1YearDuration280.51
Diluted earnings per share (5-year summary)Prior1YTDDuration-
Diluted earnings per share (5-year summary)CurrentYTDDuration-
Diluted earnings per share (5-year summary)Prior1YearDuration-
Equity to asset ratio (5-year summary)Prior1QuarterInstant0.710
Equity to asset ratio (5-year summary)CurrentQuarterInstant0.703
Equity to asset ratio (5-year summary)Prior1YearInstant0.707
Net cash provided by used in operating activities (5-year summary)Prior1YTDDuration1493735000JPY
Net cash provided by used in operating activities (5-year summary)CurrentYTDDuration1175508000JPY
Net cash provided by used in operating activities (5-year summary)Prior1YearDuration2973629000JPY
Net cash provided by used in investing activities (5-year summary)Prior1YTDDuration-149350000JPY
Net cash provided by used in investing activities (5-year summary)CurrentYTDDuration1123893000JPY
Net cash provided by used in investing activities (5-year summary)Prior1YearDuration-882828000JPY
Net cash provided by used in financing activities (5-year summary)Prior1YTDDuration-984550000JPY
Net cash provided by used in financing activities (5-year summary)CurrentYTDDuration-702630000JPY
Net cash provided by used in financing activities (5-year summary)Prior1YearDuration-998184000JPY
Cash and cash equivalents (5-year summary)Prior1QuarterInstant13269917000JPY
Cash and cash equivalents (5-year summary)CurrentQuarterInstant15658644000JPY
Cash and cash equivalents (5-year summary)Prior1YearInstant13959093000JPY
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember8656780
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember8656780
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant8656780
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant8656780
Number of shares heldCurrentQuarterInstant_No1MajorShareholdersMember3350580
Shareholding ratioCurrentQuarterInstant_No1MajorShareholdersMember0.4137

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-03-31pass
balance sheet identityconsolidated 2024-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net assetsconsolidated 2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass